Phospholipid Transfer Protein Mutations In Dyslipidemias
Phospholipid Transfer Protein Mutations In Dyslipidemias
批准号:
6698063
负责人:
MARY B ENGLER
金额:
$9.92万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-01 至 2006-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by the applicant)
Cardiovascular disease(CVD) is the leading cause of death in the western world.
Increased CVD risk is associated with low levels of high-density lipoprotein
(HDL). HDL deficiency is one of the most important causes of coronary artery
disease and yet, the least understood of lipid disorders. Phospholipid transfer
protein (PLTP) is an important regulator of HDL metabolism and may be a
potential antiatherogenic factor in plasma. Mutations in the PLTP gene that
compromise PLTP function may have significant implications for development of
atherosclerotic vascular disease. The specific aims of the clinical genetics
training include: 1. To acquire clinical and research training in the genetic
basis of cardiovascular disease. 2. To conduct research which will advance the
principal investigator's knowledge and skills as a genetics researcher and for
continued generation of original discovery in the genetics of cardiovascular
disease. Specific aims related to the proposed research include: 1) To
determine the genetic cause of HDL deficiency by screening individuals with
altered HDL and/or PLTP levels for variations in the PLTP gene by denaturing
gradient gel electrophoresis. 2) To employ 'brute force' sequencing to scan the
immediate promoter region of the PLTP gene in these individuals to find
mutations that alter the function of PLTP. 3) To genotype polymorphisms
revealed by mutation detection methodologies, primarily by development of
restriction fragment length polymorphism assays so as to develop a means of
studying case-control sample populations. 4) To discover potential ethnic
influences on HDL metabolism. 5) To characterize biochemical effects of genetic
variants identified in aims 1-3 by conducting expression studies of variant
alleles to assess their functional significance, thus, elucidating the
mechanisms by which the mutations act. Coursework in Genetics and Clinical
Research will provide the didactic foundation. Training in laboratory
methodology and analysis as well as in the UCSF Lipid Clinic will be obtained.
The research objectives are to provide vitalinsight into the role of PLTP in
HDL deficient states as a paradigm for methodology that can be applied to any
gene locus in the search for genetic causes of heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phospholipid Transfer Protein Mutations In Dyslipidemias
-
批准号:6620553
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2002
-
负责人:MARY B ENGLER
-
依托单位:
Phospholipid Transfer Protein Mutations In Dyslipidemias
-
批准号:6418755
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2002
-
负责人:MARY B ENGLER
-
依托单位:
Diet, Endothelial Function and Pediatric Hyperlipidemia
-
批准号:7632787
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2000
-
负责人:MARY B ENGLER
-
依托单位:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
-
批准号:2256896
-
项目类别:
-
资助金额:$9.3万
-
财政年份:1992
-
负责人:MARY B ENGLER
-
依托单位:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
-
批准号:3476456
-
项目类别:
-
资助金额:$10.95万
-
财政年份:1992
-
负责人:MARY B ENGLER
-
依托单位:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
-
批准号:2256894
-
项目类别:
-
资助金额:$7.9万
-
财政年份:1992
-
负责人:MARY B ENGLER
-
依托单位:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
-
批准号:2256895
-
项目类别:
-
资助金额:$8.79万
-
财政年份:1992
-
负责人:MARY B ENGLER
-
依托单位:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
-
批准号:3476457
-
项目类别:
-
资助金额:$7.56万
-
财政年份:1992
-
负责人:MARY B ENGLER
-
依托单位:
海外基金